|
HS Code |
892857 |
| Name | 3-Bromobenzylamine |
| Cas Number | 5032-27-3 |
| Molecular Formula | C7H8BrN |
| Molecular Weight | 186.05 g/mol |
| Appearance | Colorless to pale yellow liquid |
| Boiling Point | 243 °C |
| Density | 1.486 g/cm³ |
| Refractive Index | 1.597 |
| Purity | Typically ≥ 98% |
| Synonyms | m-Bromobenzylamine, 1-(3-Bromophenyl)methanamine |
| Smiles | C1=CC(=CC(=C1)Br)CN |
| Inchi | InChI=1S/C7H8BrN/c8-7-3-1-2-6(4-7)5-9/h1-4H,5,9H2 |
| Storage Temperature | 2-8 °C |
| Solubility | Soluble in water and organic solvents |
As an accredited 3-Bromobenzylamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A clear glass bottle containing 25 grams of 3-Bromobenzylamine, securely sealed with a screw cap and labeled for laboratory use. |
| Shipping | 3-Bromobenzylamine is shipped as a hazardous chemical, typically in tightly sealed containers to prevent leaks and contamination. Packages are clearly labeled according to international shipping regulations and may require temperature control. Appropriate safety documentation, such as SDS, accompanies the shipment to ensure compliance with handling and transport standards. |
| Storage | 3-Bromobenzylamine should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from sources of ignition and incompatible substances such as strong oxidizers and acids. Protect it from moisture and direct sunlight. Properly label the container and keep it away from food and drink. Follow all relevant safety guidelines and regulations for chemical storage. |
Applications of 3-Bromobenzylamine in Industrial ManufacturingOur in-house production of 3-Bromobenzylamine supports diverse industrial value chains, with each application aligned to established technical, regulatory, and quality frameworks. Below we outline key downstream scenarios where our material serves as a critical intermediate in specialized manufacturing environments. 1. Pharmaceutical Active Ingredient Synthesis3-Bromobenzylamine functions as a core building block in the synthesis of select pharmaceutical active ingredients, notably in the development of antihypertensive drug candidates and certain central nervous system (CNS) modulators. It enters the pathway through amide or urea coupling reactions, facilitating the structure–activity optimization essential for drug efficacy and metabolic stability. The amine group offers flexible derivatization, enabling chemists to introduce pharmacologically relevant motifs while maintaining strict process control as dictated by cGMP manufacturing requirements. Formulators adjust its input ratio based on targeted molecular yields and side product minimization during scaled-up multi-step syntheses. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediates ProductionIn the agrochemicals sector, formulators leverage this compound as a selective intermediate for synthesizing novel fungicide and herbicide actives. Its bromine atom provides a defined handle for further aryl substitution, supporting the creation of heterocyclic frameworks and benzyl-linked derivatives that target specific pests or weeds. Process engineers manage the addition during key condensation stages to optimize yield, while conforming to global crop protection chemical standards and environmental regulations governing trace residues. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Dye and Pigment Precursor ManufacturingThis aromatic amine enables the targeted synthesis of specialty dyes for electronic, textile, and printing applications, providing a brominated entry point for sequential diazotization and azo-coupling or Suzuki–Miyaura cross-coupling reactions. Precision in the compound’s integration permits the formation of distinct color profiles and enhanced photostability. Dye manufacturers comply with international eco-toxicological and product labeling standards, particularly where the end-use includes children’s goods or sensitive industrial zones. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Polymer Modifier SynthesisIn engineering polymer production, 3-Bromobenzylamine acts as a reactive modifier, imparting unique physical and chemical properties to epoxy resins and specialty polyamides. It participates in the chain extension or crosslinking process, supporting the manufacture of polymers with controlled thermal resistance, adhesion, or functional group compatibility. Manufacturers operate under strict quality and environmental risk management systems, especially for resins targeted at electronics and transportation industries. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Chemical Reference Standard and Analytical Reagent ProductionAccredited reference laboratories and standards bodies use high-purity grades of this compound as analytical reagents and calibration standards. The physical and chemical consistency of the product ranks as a critical parameter for trace analysis and calibration in chromatographic and spectrometric methods. Production and supply adhere to the highest purity assurance frameworks, aligning with global criteria for laboratory analytical methodology. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-Bromobenzylamine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing 3-Bromobenzylamine has been a core part of our daily operations for well over a decade. As one of our mainstay fine chemicals, we have followed this product through cycles of growth in several industries—including pharmaceuticals, agricultural intermediates, and specialty materials. What we’ve learned from years behind the reactor is that this chemical offers unique opportunities and challenges, both in its handling on the shop floor and in the ways that downstream chemists use it.
Our 3-Bromobenzylamine, identified by the CAS number 616-72-2, comes as a white solid or sometimes a pale yellow crystalline powder, depending on minute variations in batch cooling conditions. The molecular weight sits firmly at 186.05 g/mol. The structure brings together a benzylamine core and a bromine at the meta position. This configuration gives it characteristics that set it apart from its ortho and para analogs, both during synthesis and in reactivity later on.
Not every bromobenzylamine behaves the same; the meta isomer we manufacture stands out. For example, in cross-coupling or amide-bond-forming reactions, our 3-Bromobenzylamine delivers consistent yields and fewer side products than what we’ve observed with the 2- or 4- isomers under similar conditions. This holds true across a spectrum of projects, from milligram-scale medicinal chemistry runs to multi-kilo seed batches for process development.
The laboratories and QA teams here track performance not just on specs, but on actual handling experience downstream. Our material comes with a minimum purity of 99%, measured by both HPLC and NMR. This figure stands out not only on paper but in day-to-day synthesis. Lower purities, which flood the market through less scrupulous channels, often contain halogenated side-products or over-brominated fragments that wreak havoc on scale-up campaigns. We have decommissioned entire synthesis steps in the past due to supplier inconsistencies—which is why we control bromination and subsequent amination all in-house.
From lab work to pilot plant, our production process has been optimized for both safety (bromination reactions, especially at larger scale, cannot be rushed) and for product uniformity. Customers who work at gram and multi-tonne projects both have different pain points. For the scale-up chemist, our focus isn’t just on purity, but also how easily the compound dissolves, which is strictly regulated by controlling particle size during isolation. For small-molecule R&D teams, quick dissolution in common polar solvents and low water content trouble-shoots many routine roadblocks, making batch-to-batch reproducibility a non-issue.
The amine’s basicity profile actually impacts subsequent N-acylation steps, and we’ve seen synthetic teams fail to achieve targeted conversions when working with off-spec imports where the bromo position is not perfectly controlled. That’s not just theory—one client saw their impurity profile drop from 2.5% to below 0.3% after reformulating with our consistent supply.
Over the years, we’ve shipped to teams making everything from kinase inhibitors to light-stable chemical linkers. In pharmaceutical intermediate synthesis, 3-Bromobenzylamine is prized for its dual functional handles. Chemists frequently deploy the amine group in straightforward amidations or as the nucleophile in reductive amination. The bromo handle adds extra flexibility, especially for constructing more complex frameworks by Suzuki or Ullmann couplings.
For research heavyweights, this functional duality means one molecule can serve two synthetic strategies—build a new linkage or introduce aromatic diversity via further coupling. In our conversations with process chemists, this flexibility often translates to shorter synthetic routes, fewer purification steps, and less waste. In fact, a major biotech client used this compound to cut their API route length by two steps, unlocking new patent space for their team.
Not every amine is made the same. Competing benzylamines with different halogen placements tend to increase unwanted rearrangements or hydrolysis issues under moderately basic conditions. Through hands-on troubleshooting with R&D collaborators, we’ve confirmed that the meta-bromo orientation opens up more options without introducing unwanted reactivity at adjacent ring positions.
From the factory worker’s perspective, the main challenge lies in bromine handling and managing air quality during the bromination. Scrupulous in-process controls and operator training prevent over-bromination and ensure no uncontrolled exotherms occur. Every operator who’s run the reactors knows how vigilance on temperature delays at the phase transfer step keeps side reactions at bay. Our process uses a proprietary quench system, minimizing exposure and protecting both product and people.
In agricultural chemistry intermediates, formulators have told us that our 3-Bromobenzylamine’s high amine content boosts crop-protection activity when integrated into active ingredient frameworks. We stick to tight residual solvent levels for this reason—solvent contamination in active intermediates has derailed entire pilot lots in the past, causing clients measurable losses. Our first-hand experience has driven us to install inline solvent stripping and triple filter setups specifically for this product line.
We’ve seen plenty of situations where researchers substitute 2-Bromobenzylamine or even 4-Bromobenzylamine for our product. Those who make the swap quickly observe big differences in both reactivity and byproduct formation. Meta substitution avoids some of the steric crowding that the ortho position brings—clearing the way for more selective cross-coupling and greater tolerance of functional groups like esters or sulfones on the ring.
Another point of difference revolves around physical properties. The 3- isomer consistently melts several degrees higher than its 2- counterpart, helping downstream operations like recrystallization and drying proceed more efficiently, with less risk of melt-related runoff or clumping during bulk storage. Our clients have noted fewer clogs in their weigh stations and less material loss during transit as a result.
One longstanding collaboration with an academic research center focused on CNS-active compounds has highlighted another difference. Their comparative runs with the para isomer produced unstable peptide conjugates under physiological pH, likely due to subtle electronic effects. The meta product delivered stable conjugation profiles, confirmed with weeks-long stability data, which we’ve validated several times in our own pilot studies.
We put a premium on traceability, not just for regulatory compliance but for dependability at scale. Instead of relying on spot-market bromine or external intermediates, we source all major feedstocks ourselves. Every batch gets barcoded and tracked from raw ingredient to finished goods. This visibility lets us minimize batch-to-batch variance, flag anomalies before packaging, and respond with precise root-cause analysis if any question ever arises.
All our operators and process chemists undergo regular Hazmat and GMP training. We see the impact of this not just during audits, but in our own occupational health statistics. Lower incident rates, cleaner shift-change handovers, and higher operator retention directly correlate with fewer late-stage deviations and higher on-time dispatch for high-value fine chemicals like 3-Bromobenzylamine.
This product isn’t just about performance on the bench—it’s about responsibility at every phase. We designed a closed-loop system for all volatile organics, reclaiming over 90% of our plant’s process solvents for reconditioning. We invested in high-efficiency scrubbers to handle not only workplace exposures but also environmental limits. Our process water recycling initiative, piloted during the early years of commercial production, has become a model adopted at our other plants.
Brominated intermediates often get a bad reputation due to pollution and health hazards associated with less responsible manufacturers. We’ve seen first-hand what happens when safety protocols are cut. Our teams run regular emergency response drills, and we provide every worker—from reactor staff to packaging floor—direct access to medical checkups and safety committees.
Quality isn’t a once-a-year audit for us. Instead, every step in our workflow runs with in-line HPLC checks and final NMR validation. We have spent years building relationships with downstream users who run our samples through their own stability, solubility, and reactivity panels. Their data and feedback help guide our process tweaks, and occasionally even lead us to reformulate our purification or packing methods.
A recent example: a pharma client flagged a persistent impurity in their high-throughput screens. Working with their teams, we pinpointed a feedstock trace byproduct that was below standard detection—by doubling our resolution and extending our chromatographic windows, we eliminated the issue in two production cycles, improving product shelf life by over a year in accelerated studies. Experience on the production side gives our team the insight to rapidly diagnose and act on these challenges.
Over time, packaging failures and mishaps in transit have shaped how we pack and ship 3-Bromobenzylamine. We provide this material in thick-walled HDPE drums with tamper-evident sealing for bulk loads, and in nitrogen-flushed glass bottles for lab-scale deliveries. Each package is marked with full batch numbers and desiccant pouches, especially tuned for rainy seasons when humidity threatens material stability. Working directly with port handling teams, we’ve cut down damage rates and preserved product integrity all the way to client bench-tops.
For customers in climates with high humidity, the extra investment in moisture barriers has repeatedly demonstrated real value—in one instance, preventing a shipment loss valued at several hundred thousand dollars. Such iterations stem directly from listening to what our partners have experienced in the field, then building improvements into the manufacturing cycle.
Living alongside this industry means we see the problems that matter: purity drift between orders, unpredictable shelf stability, and inconsistencies with off-brand materials flooding global markets. By managing every step of 3-Bromobenzylamine from bromination to finishing, we remedy these pain points.
Laboratory teams count on receiving a product that functions as standard, month over month, without the need for revalidation. Cost overruns from failed scale-ups or crashed purification steps harm everyone in the supply chain. By sharing our batch data, invitees can trace exactly what’s in each shipment.
We keep technical discussions open with both routine and first-time buyers. Our technical support desk is staffed by chemists, not by sales representatives, so troubleshooting never waits for a drawn-out escalation. Direct access between our shop and our clients speeds up everything: troubleshooting, custom modifications, and quick pivots in scale or packaging when R&D directions evolve.
As molecule builders ourselves, we believe the future of chemical manufacturing depends on open standards, transparent data, and a willingness to adopt both new technologies and improved safety protocols. For 3-Bromobenzylamine, our experience stands as a guarantee—chemists receive a product purpose-built for creative, reproducible work both at the lab bench and in full-scale production.
Nothing is static in our field. Formulators continue to uncover new uses for 3-Bromobenzylamine in resin modification, bioconjugation, and next-generation agriculture seed coatings. We watch these innovations closely, many times collaborating directly on pilot studies or customized grades to fit a specific challenge. Our role as manufacturer—rather than distributor or trader—lets us offer such agility directly, unfiltered by the shifting priorities of bulk markets.
Every day that a batch ships out, our team stands behind it with a blend of pride, accumulated know-how, and readiness to solve the next problem that emerges in chemical innovation. The future of 3-Bromobenzylamine, as we see it, will always tie back to the craftsmanship and vigilance of the teams who make it, and the end-users who do something new with it every year.